|
|||||
|
|
Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes |
|
| Authors: | Yanai Hidekatsu Masui Yoshinori Yoshikawa Reo Kunimatsu Junwa Kaneko Hiroshi |
| Institution: | Hidekatsu Yanai, Yoshinori Masui, Reo Yoshikawa, Junwa Kunimatsu, Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Chiba 272-8516, Japan;Hiroshi Kaneko, Department of Rheumatology, Kohnodai Hospital, National Center for Global Health and Medicine, Chiba 272-8516, Japan |
| Abstract: | The addition of the dipeptidyl peptidase-4 (DDP-4) inhibitor has been reported to achieve greater improvements in glucose metabolism with fewer adverse events compared to increasing the metformin dose in type 2 diabetic patients. We present a patient with steroid-induced diabetes whose blood glucose levels were ameliorated by the use of the DPP-4 inhibitor, showing that the DPP-4 inhibitors may be an effective and safe oral anti-diabetic drug for steroid-induced diabetes. |
| Keywords: | Dipeptidyl peptidase-4 Nateglinide Sitagliptin Steroid-induced diabetes |
| 本文献已被 PubMed 等数据库收录！ | |